플러스100%마이너스

  • 화면크기
통합검색

한의약융합데이터센터


근거중심한의약 DB

Home > 한의약융합데이터센터 > 근거중심한의약 DB
Title

Efficacy and Safety of Curcumin and Curcuma longa Extract in the Treatment of Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trial.

Authors

Zeng L, Yang T, Yang K, Yu G, Li J, Xiang W, Chen H.

Journal

Front Immunol.

Year

2022

Vol (Issue)

13

Page

891822.

doi

10.3389/fimmu.2022.891822.

PMID

35935936

Url

http://www.ncbi.nlm.nih.gov/pubmed/35935936

MeSH

Arthritis, Rheumatoid* / drug therapy
Curcuma
Curcumin* / adverse effects
Humans
Inflammation / drug therapy
Osteoarthritis* / drug therapy
Plant Extracts
Randomized Controlled Trials as Topic
Spondylitis, Ankylosing* / drug therapy

Keywords

Curcuma longa extract; ankylosing spondylitis; curcumin; juvenile idiopathic arthritis; meta-analysis; osteoarthritis; rheumatoid arthritis; systematic review

한글 키워드

KMCRIC summary and commentary

없음

Korean Study

N

Abstract

Background: Modern pharmacological research found that the chemical components of Curcuma longa L. are mainly curcumin and turmeric volatile oil. Several recent randomized controlled trials (RCT) have shown that curcumin improves symptoms and inflammation in patients with arthritis.

Methods: Pubmed, Cochran Library, CNKI, and other databases were searched to collect the randomized controlled trials (RCTs). Then, the risk of bias of RCTs were assessed and data of RCTs were extracted. Finally, RevMan 5.3 was utilized for meta-analysis.

Results: Twenty-nine (29) RCTs involving 2396 participants and 5 types of arthritis were included. The arthritis included Ankylosing Spondylitis (AS), Rheumatoid Arthritis (RA), Osteoarthritis (OA), Juvenile idiopathic arthritis (JIA) and gout/hyperuricemia. Curcumin and Curcuma longa Extract were administered in doses ranging from 120 mg to 1500 mg for a duration of 4-36 weeks. In general, Curcumin and Curcuma longa Extract showed safety in all studies and improved the severity of inflammation and pain levels in these arthritis patients. However, more RCTs are needed in the future to elucidate the effect of Curcumin and Curcuma longa Extract supplementation in patients with arthritis, including RA, OA, AS and JIA.

Conclusion: Curcumin and Curcuma longa Extract may improve symptoms and inflammation levels in people with arthritis. However, due to the low quality and small quantity of RCTs, the conclusions need to be interpreted carefully.

Keywords: Curcuma longa extract; ankylosing spondylitis; curcumin; juvenile idiopathic arthritis; meta-analysis; osteoarthritis; rheumatoid arthritis; systematic review.

Copyright © 2022 Zeng, Yang, Yang, Yu, Li, Xiang and Chen.

국문초록

N

Language

영어

첨부파일